Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drug Discovery: Overview01:26

Drug Discovery: Overview

12.0K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
12.0K
Protein Networks02:26

Protein Networks

4.6K
An organism can have thousands of different proteins, and these proteins must cooperate to ensure the health of an organism. Proteins bind to other proteins and form complexes to carry out their functions. Many proteins interact with multiple other proteins creating a complex network of protein interactions.
These interactions can be represented through maps depicting protein-protein interaction networks, represented as nodes and edges. Nodes are circles that are representative of a protein,...
4.6K
Protein Networks02:26

Protein Networks

2.9K
2.9K
Network Covalent Solids02:18

Network Covalent Solids

16.3K
Network covalent solids contain a three-dimensional network of covalently bonded atoms as found in the crystal structures of nonmetals like diamond, graphite, silicon, and some covalent compounds, such as silicon dioxide (sand) and silicon carbide (carborundum, the abrasive on sandpaper). Many minerals have networks of covalent bonds.
To break or to melt a covalent network solid, covalent bonds must be broken. Because covalent bonds are relatively strong, covalent network solids are typically...
16.3K
Hybridoma Technology01:31

Hybridoma Technology

17.8K
Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...
17.8K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

4.3K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
4.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Secretome and Pathway Analysis of Stress Induced Disc Degeneration In Vitro.

JOR spine·2026
Same author

Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitis.

Nature genetics·2026
Same author

Intragraft clonal expansion of cytotoxic CD8<sup>+</sup> and CD4<sup>+</sup> T cells in antibody-mediated kidney transplant rejection.

Kidney international·2026
Same author

Integrative multi-omics defines melanoma drug response networks and ARID1A-dependent resistance mechanisms.

Molecular systems biology·2026
Same author

A Targetable Developmental Program Coregulates Angiogenesis and Immune Evasion in Melanoma.

Cancer discovery·2026
Same author

Intracellular Detection of <i>C. acnes</i> and <i>S. aureus</i> in Non-Herniated Human Intervertebral Discs: Implications for Catabolic Signaling Pathways.

JOR spine·2025
Same journal

IdopNetworks: How to infer the individualized genetic architecture of genomics for precision medicine.

Drug discovery today·2026
Same journal

Organoid-AI platforms need integrated governance in drug discovery.

Drug discovery today·2026
Same journal

Inorganic nanoparticles for diagnostics, drug delivery and therapy for solid tumors.

Drug discovery today·2026
Same journal

HDAC11 as a potential therapeutic target for Alzheimer's disease.

Drug discovery today·2026
Same journal

From biologics to small-molecule modulators: The evolving landscape of interleukin-targeted therapeutics.

Drug discovery today·2026
Same journal

Targeting the GLP-1 receptor pathways for dual management of obesity and depression.

Drug discovery today·2026
See all related articles

Related Experiment Video

Updated: Feb 16, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.3K

Network-based technologies for early drug discovery.

Chris Fotis1, Asier Antoranz2, Dimitris Hatziavramidis1

  • 1National Technical University of Athens, Athens, Greece.

Drug Discovery Today
|January 3, 2018
PubMed
Summary
This summary is machine-generated.

New computational tools enhance traditional drug discovery by integrating systems biology and omics technologies. This holistic approach aids in identifying promising drug targets and compounds for diseases.

More Related Videos

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

Related Experiment Videos

Last Updated: Feb 16, 2026

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis
08:49

Incorporating Target Protein Structure Flexibility and Dynamics in Computational Drug Discovery Using Ensemble-Based Docking Analysis

Published on: June 20, 2025

1.3K
Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish
07:50

Facilitating Drug Discovery: An Automated High-content Inflammation Assay in Zebrafish

Published on: July 16, 2012

14.8K
Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery
06:26

Nano-Differential Scanning Fluorimetry for Screening in Fragment-based Lead Discovery

Published on: May 16, 2021

5.6K

Area of Science:

  • Computational biology
  • Pharmacology
  • Drug discovery

Background:

  • Traditional drug discovery faces high attrition rates despite successes.
  • Systems-oriented approaches and omics technologies offer new avenues.
  • Computational tools are emerging to improve drug development.

Purpose of the Study:

  • To explore how systems-biology and omics technologies can refine drug discovery.
  • To highlight the utility of computational tools in identifying drug targets and compounds.
  • To advocate for a holistic approach in early-stage drug development.

Main Methods:

  • Utilizing systems-biology and/or pharmacology.
  • Leveraging omics technologies.
  • Employing computational tools based on biomolecular pathways and interaction networks.

Main Results:

  • Computational tools enable a more informed drug discovery process.
  • Systematic analysis of diseases and drug interactions is facilitated.
  • Identification of promising targets and compounds is improved.

Conclusions:

  • Systems-oriented approaches offer a holistic strategy for drug discovery.
  • Computational tools are crucial for unraveling disease mechanisms and drug footprints.
  • This integrated approach promises to increase the success rate of drug development.